Recombinanthuman FVIII (rhFVIII) for hemophilia A treatment may be obtained from culturedmammalian cells purified to clinical grade by affinity chromatography and three orfour rounds of conventional chromatography and virus-inactivated bysolvent-detergent treatment and nanofiltration or heating. Here, F8 is linked to hemophilia A.